Upgrade to SI Premium - Free Trial

Moderna (MRNA) PT Lowered to $157 at Piper Sandler

August 2, 2024 7:40 AM
Piper Sandler analyst Edward Tenthoff lowered the price target on Moderna (NASDAQ: MRNA) to $157.00 (from $214.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles